Daiichi Sankyo, Inc Hiring for Director, Disease Area Strategy Team, GU Cancers job in Basking Ridge Full Time

Join a Legacy of Innovation 110 Years and Counting!

Company is committed to diversity and inclusion. We are an equal opportunity employer including veterans and people with disabilities.

Summary

Reporting to the Disease Area Strategy Team (DAST) Lead for GU Cancer, this position is an integral part of R&D and partners with the DAST Lead to build and execute a disease area strategy across the ADC portfolio plus emerging pipeline assets to advance our research and development. This role will lead workstreams with highly matrixed cross-functional and cross-regional teams. Stakeholders include many functions within R&D and Commercial, and Medical Affairs. Responsibilities will be both process/capability development for a relatively new functional group and high-complexity disease work to support critical strategic choices for the clinical program. The DAST Director will collaborate with the DAST Lead and core DAST membership to build out disease-focused resources and capabilities. The individual will be a key contributor for a unified Disease Area Strategy across the Oncology Portfolio and organization, support effective communication and collaboration between DAST members and other functional stakeholders & subject matter experts, and support process/capability development to enable the effective integration of DAST into the fabric of Daiichi Sankyo.

Responsibilities

– Facilitate pull-through of the disease area strategy through collaboration with clinical development team (ADC portfolio plus emerging pipeline assets) and key functions.
– Contribute to data generation proposals and decision-making that optimizes Daiichi Sankyo’s presence in Lung Cancer [Breast Cancer] based on customer insights, external landscape, and internal information including overall product development plans.
– Proactive planning for asset milestones to account for disease perspective, anticipated external reaction, and cross-asset impact.
– Lead working group on lung [breast] cancer competitive strategy by assessing competitive impact to the disease strategy and the strategic choices for clinical development and data generation
– Develop and define DAST best practices including development and use of qualitative and quantitative methods to provide disease perspective for clinical development planning, while working in collaboration with the Global Project Teams, Portfolio Prioritization Team, Business Development, Translational Medicine, and other related functions.
– Support initiatives that focus on advancing DAST capabilities and/or installing disease strategy priorities throughout the organization.
– Set annual/quarterly goals and KPIs, effectively manage department budget and resource allocation, proactively identify needs for process capability development/improvements, lead process capability development/improvements, and identify organizational needs to ensure DAST success
– Actively contributes to progressing the Global TA Strategy department as strategic influencer and other functional initiative.

Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.
Education Qualifications (from an accredited college or university)

– Bachelor’s Degree with relevant years of experiences required and
– Advanced degree (Master, MBA or PhD) with additional relevant experience (preferred) preferred

Experience Qualifications

REQUIRED

• 7-10 years of oncology in the biopharma/Healthcare industry.
• 3-5 years of experience working on GU Cancers.
• Proven track record in a highly matrixed team with strong interpersonal skills to influence cross-functional and cross-regional senior leaders with collaborative mindset

PREFERRED

• Prior experience in project management or leading change management initiatives.
• Prior experience in clinical development, Medical Affairs, or Global Marketing.
• Demonstrated success in planning and executing strategies for global drug development, commercialization, and life cycle management.
• Strong expert network and can consult key external disease experts (KEE)

Travel Ability to travel up to 10% domestic and/or international travel
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.